Here, we examine the evidence that cardiac resynchronization is indeed the mechanism by which atrio-biventricular pacing exerts its effects.

We included studies involving patients with heart failure receiving optimal medical therapy that compared cardiac resynchronization therapy with optimal medical therapy alone, or cardiac ...

Cardiac Resynchronization Therapy Market Segment Analysis: In the product type segment of cardiac resynchronization therapy, the CRT-defibrillators category is expected to have a significant ...

Given this background, device therapies, such as ventricular resynchronization, represent a promising new modality in the treatment of HF patients.

Douglas, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Douglas Insights is looking to grow its comparison engine and conversely included an analysis on Cardiac Resynchronization Therapy (CRT) Devices Market ...

Contemporary cardiac resynchronization therapy (CRT) devices are equipped with reliable and extensive diagnostic and memory features yielding full disclosure of the frequency, duration, and ...

A pacemaker-like device restored heart function in a group of cancer survivors—mostly women with breast cancer—who had suffered from heart failure as a result of chemotherapy, a study in the ...

But six months after cardiac resynchronization therapy, Dennis and others in the study saw their EFs rise into the normal range.

Cardiac resynchronization therapy has been shown to benefit patients with heart failure despite optimal medical therapy, but the effect on long-term outcomes is unknown.

Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.